摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(m-fluoro)phenyl-4,5-imidazole dicarboxylic acid | 1258599-87-9

中文名称
——
中文别名
——
英文名称
2-(m-fluoro)phenyl-4,5-imidazole dicarboxylic acid
英文别名
2-(3-fluorophenyl)-1H-imidazole-4,5-dicarboxylic acid
2-(m-fluoro)phenyl-4,5-imidazole dicarboxylic acid化学式
CAS
1258599-87-9
化学式
C11H7FN2O4
mdl
——
分子量
250.186
InChiKey
NHZNPJYDBNMLLJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    103
  • 氢给体数:
    3
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    cobalt(II) chloride hexahydrate 、 2-(m-fluoro)phenyl-4,5-imidazole dicarboxylic acid乙醇 为溶剂, 反应 96.0h, 以51.7%的产率得到[Co(2-(m-fluoro)phenyl-4,5-imidazole-dicarboxylic acid)2(H2O)2]*4H2O
    参考文献:
    名称:
    三个取代的咪唑二羧酸盐基金属(II)超分子用于质子传导
    摘要:
    为了寻求新型的质子导电材料,我们已经成功地合成了三种新型的氢键超分子配合物[M(m -FPhH 2 IDC)2(H 2 O)2 ]·4H 2 O(M = Cd(1);)。 Co(2))(m -FPhH 3 IDC = 2-(m-氟)苯基-4,5-咪唑二羧酸)和[Mn(m -FPhH 2 IDC)2(2,2'-bipy)] ·水2 O(3)(2,2'-bipy = 2,2'-bipyridine)在水(溶剂)热条件下。分析晶体结构和验证的热,水和化学稳定性后1 - 3,的质子传导率1 - 3中的水蒸汽已被测定,结果表明,它们的质子电导率随着温度和相对湿度(RH)相应增加。在98%RH和100℃,的质子传导率1 - 3达到2.77×10的最高值-4,3.42×10 -5和4.61×10 -5 小号厘米-1, 分别。通过PXRD确定和活化能计算的质子转移机制,1 - 3已经被提出。我们的研究表明
    DOI:
    10.1016/j.jssc.2019.121129
  • 作为产物:
    参考文献:
    名称:
    Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution
    摘要:
    Pin1 is an emerging oncology target strongly implicated in Ras and ErbB2-mediated tumourigenesis. Pin1 isomerizes bonds linking phospho-serine/threonine moieties to proline enabling it to play a key role in proline-directed kinase signalling. Here we report a novel series of Pin1 inhibitors based on a phenyl imidazole acid core that contains sub-mu M inhibitors. Compounds have been identified that block prostate cancer cell growth under conditions where Pin1 is essential. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.09.063
点击查看最新优质反应信息

文献信息

  • [EN] PHARMACEUTICAL COMPOSITIONS AND COMBINATIONS COMPRISING INHIBITORS OF THE ANDROGEN RECEPTOR AND USES THEREOF<br/>[FR] COMPOSITIONS ET COMBINAISONS PHARMACEUTIQUES COMPRENANT DES INHIBITEURS DU RÉCEPTEUR DES ANDROGÈNES ET UTILISATIONS DE CELLES-CI
    申请人:ESSA PHARMA INC
    公开号:WO2020198712A1
    公开(公告)日:2020-10-01
    The present disclosure generally relates to pharmaceutical compositions and combinations comprising an androgen receptor N-terminal domain inhibitor or an inhibitor and a second therapeutically active agent, such as an CDK4/6 inhibitor, a Pin1 inhibitor (inhibitor of peptidyl-prolyl cis/trans isomerases), or an antiandrogen. In particular, the present disclosure relates to pharmaceutical compositions and combintaions useful for treatment of various cancers, for example breast cancer and prostate cancer. Further, the present disclosure relates administering an androgen receptor N-terminal domain inhibitor in combination with radiation therapy for treatment of various cancers.
    本公开涉及药物组合和制剂,包括雄激素受体N端域抑制剂或抑制剂和第二种治疗活性剂,例如CDK4/6抑制剂、Pin1抑制剂(肽前脯氨酸顺反异构酶抑制剂)或抗雄激素。特别地,本公开涉及用于治疗各种癌症的药物组合和制剂,例如乳腺癌和前列腺癌。此外,本公开还涉及将雄激素受体N端域抑制剂与放射治疗联合使用以治疗各种癌症。
  • Two high tunable proton-conducting cobalt(II) complexes derived from imidazole multi-carboxylate-based ligand
    作者:Zhi-Qiang Shi、Ning-Ning Ji、Jian-Ping Zhang、Xian-Lei Xu、Gang Li
    DOI:10.1016/j.jssc.2020.121313
    日期:2020.6
    carboxyl and imidazole groups exist which are beneficial for the transfer of protons. Therefore, the temperature- and humidity-dependent proton conduction properties of the two complexes were investigated in detail. 1 and 2 have the optimal proton conductivities of 8.15 × 10-4 S cm-1 and 1.31 × 10-5 S cm-1 at 373 K under 98% RH, respectively, which can be compared to the reported imidazole dicarboxylate-based
    利用多功能的m -FPhH 3 IDC配体,形成两个高度稳定的Co(II)配合物,即[Co(m -FPhH 2 IDC)2(2,2'-bipy)]·H 2 O(1)和[CO(米-FPhH 2 IDC)2(苯)〕·H 2 O(2)(米-FPhH 3 IDC = 2-(米-氟)苯基-4,5-咪唑二羧酸,2,2- ′-bipy = 2,2′-联吡啶,phen = 1,10-菲咯啉已被水热合成并在结构上表征。1和2发现在pH值为1至11的水溶液以及沸水中,它们稳定。结构分析结果表明,由水分子,羧基和咪唑基形成的1和2中存在丰富的氢键网络,有利于质子的转移。因此,详细研究了两种配合物的温度和湿度依赖性质子传导性质。1和2的最佳质子电导率分别为8.15×10 -4  S cm -1和1.31×10 -5  S cm -1在373 K下,相对湿度为98%时,可以与已报道的基于咪唑二羧酸酯的配合物进行比较。另外,对质子传导机理进行了详细研究。
  • PHARMACEUTICAL COMPOSITIONS AND COMBINATIONS COMPRISING INHIBITORS OF THE ANDROGEN RECEPTOR AND USES THEREOF
    申请人:ESSA Pharma, Inc.
    公开号:US20220218632A1
    公开(公告)日:2022-07-14
    The present disclosure generally relates to pharmaceutical compositions and combinations comprising an androgen receptor N-terminal domain inhibitor or an inhibitor and a second therapeutically active agent, such as an CDK4/6 inhibitor, a Pin1 inhibitor (inhibitor of peptidyl-prolyl cis/trans isomerases), or an antiandrogen. In particular, the present disclosure relates to pharmaceutical compositions and combinations useful for treatment of various cancers, for example breast cancer and prostate cancer. Further, the present disclosure relates administering an androgen receptor N-terminal domain inhibitor in combination with radiation therapy for treatment of various cancers.
  • Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution
    作者:Andrew Potter、Victoria Oldfield、Claire Nunns、Christophe Fromont、Stuart Ray、Christopher J. Northfield、Christopher J. Bryant、Simon F. Scrace、David Robinson、Natalia Matossova、Lisa Baker、Pawel Dokurno、Allan E. Surgenor、Ben Davis、Christine M. Richardson、James B. Murray、Jonathan D. Moore
    DOI:10.1016/j.bmcl.2010.09.063
    日期:2010.11
    Pin1 is an emerging oncology target strongly implicated in Ras and ErbB2-mediated tumourigenesis. Pin1 isomerizes bonds linking phospho-serine/threonine moieties to proline enabling it to play a key role in proline-directed kinase signalling. Here we report a novel series of Pin1 inhibitors based on a phenyl imidazole acid core that contains sub-mu M inhibitors. Compounds have been identified that block prostate cancer cell growth under conditions where Pin1 is essential. (C) 2010 Elsevier Ltd. All rights reserved.
  • Three substituted imidazole dicarboxylate-based metal(II) supramolecules for proton conduction
    作者:Zhi-Qiang Shi、Ning-Ning Ji、Wan-Yao Chen、Gang Li
    DOI:10.1016/j.jssc.2019.121129
    日期:2020.2
    To seek new types of proton conductive materials, we have successfully synthesized three novel hydrogen-bonded supramolecular complexes, [M(m-FPhH2IDC)2(H2O)2]·4H2O (M = Cd (1); Co (2)) (m-FPhH3IDC = 2-(m-fluoro)phenyl-4,5-imidazole dicarboxylic acid), and [Mn(m-FPhH2IDC)2(2,2′-bipy)]·H2O (3) (2,2′-bipy = 2,2′-bipyridine) under hydro(solvo)thermal conditions. After analyzing crystal structures and
    为了寻求新型的质子导电材料,我们已经成功地合成了三种新型的氢键超分子配合物[M(m -FPhH 2 IDC)2(H 2 O)2 ]·4H 2 O(M = Cd(1);)。 Co(2))(m -FPhH 3 IDC = 2-(m-氟)苯基-4,5-咪唑二羧酸)和[Mn(m -FPhH 2 IDC)2(2,2'-bipy)] ·水2 O(3)(2,2'-bipy = 2,2'-bipyridine)在水(溶剂)热条件下。分析晶体结构和验证的热,水和化学稳定性后1 - 3,的质子传导率1 - 3中的水蒸汽已被测定,结果表明,它们的质子电导率随着温度和相对湿度(RH)相应增加。在98%RH和100℃,的质子传导率1 - 3达到2.77×10的最高值-4,3.42×10 -5和4.61×10 -5 小号厘米-1, 分别。通过PXRD确定和活化能计算的质子转移机制,1 - 3已经被提出。我们的研究表明
查看更多

同类化合物

伊莫拉明 (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5-氨基-1,3,4-噻二唑-2-基)甲醇 齐墩果-2,12-二烯[2,3-d]异恶唑-28-酸 黄曲霉毒素H1 高效液相卡套柱 非昔硝唑 非布索坦杂质Z19 非布索坦杂质T 非布索坦杂质K 非布索坦杂质E 非布索坦杂质67 非布索坦杂质65 非布索坦杂质64 非布索坦杂质61 非布索坦代谢物67M-4 非布索坦代谢物67M-2 非布索坦代谢物 67M-1 非布索坦-D9 非布索坦 非唑拉明 雷西纳德杂质H 雷西纳德 阿西司特 阿莫奈韦 阿米苯唑 阿米特罗13C2,15N2 阿瑞匹坦杂质 阿格列扎 阿扎司特 阿尔吡登 阿塔鲁伦中间体 阿培利司N-1 阿哌沙班杂质26 阿哌沙班杂质15 阿可替尼 阿作莫兰 阿佐塞米 镁(2+)(Z)-4'-羟基-3'-甲氧基肉桂酸酯 锌1,2-二甲基咪唑二氯化物 铵2-(4-氯苯基)苯并恶唑-5-丙酸盐 铬酸钠[-氯-3-[(5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基苯磺酸基][4-[(3,5-二氯-2-羟基苯 铁(2+)乙二酸酯-3-甲氧基苯胺(1:1:2) 钠5-苯基-4,5-二氢吡唑-1-羧酸酯 钠3-[2-(2-壬基-4,5-二氢-1H-咪唑-1-基)乙氧基]丙酸酯 钠3-(2H-苯并三唑-2-基)-5-仲-丁基-4-羟基苯磺酸酯 钠(2R,4aR,6R,7R,7aS)-6-(2-溴-9-氧代-6-苯基-4,9-二氢-3H-咪唑并[1,2-a]嘌呤-3-基)-7-羟基四氢-4H-呋喃并[3,2-D][1,3,2]二氧杂环己膦烷e-2-硫醇2-氧化物 野麦枯 野燕枯 醋甲唑胺